Evidence map›Paper›PMID 23013659›Full record

ArticleEpidemiology and infection2013

Community incidence of pathogen-specific gastroenteritis: reconstructing the surveillance pyramid for seven pathogens in seven European Union member states.

J A Haagsma, P L Geenen, S Ethelberg, A Fetsch, F Hansdotter, A Jansen, H Korsgaard, S J O'Brien, G Scavia, H Spitznagel and 4 more

Open access · greenAbstract read
In one paragraph

Article in Epidemiology and infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. High levels of domestic transmission and drug resistance -analysis of national surveillance data for shigellosis, the Netherlands, 2018 to 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. The European Union One Health 2023 Zoonoses report.EFSA journal. European Food Safety Authority · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 8 countries.

J A HaagsmaCentrum voor Infectieziektebestrijding, Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, The Netherlands. j.haagsma@erasmusmc.nl
P L Geenen
S Ethelberg
A Fetsch
F Hansdotter
A Jansen
H Korsgaard
S J O'Brien
G Scavia
H Spitznagel
P Stefanoff
C C Tam
A H Havelaar
Med-Vet-Net Working Group
Robert Koch Institute · DEFederal Institute for Risk Assessment · DEHealth Forecasting · USIstituto Superiore di Sanità · ITLondon School of Hygiene & Tropical Medicine · GBNarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PLNational Institute for Public Health and the Environment · NLStatens Serum Institut · DKTechnical University of Denmark · DKUniversity of Liverpool · GBUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By building reconstruction models for a case of gastroenteritis in the general population moving through different steps of the surveillance pyramid we estimated that millions of illnesses occur annually in the European population, leading to thousands of hospitalizations. We used data on the healthcare system in seven European Union member states in relation to pathogen characteristics that influence healthcare seeking. Data on healthcare usage were obtained by harmonized cross-sectional surveys. The degree of under-diagnosis and underreporting varied by pathogen and country. Overall, underreporting and under-diagnosis were estimated to be lowest for Germany and Sweden, followed by Denmark, The Netherlands, UK, Italy and Poland. Across all countries, the incidence rate was highest for Campylobacter spp. and Salmonella spp. Incidence estimates resulting from the pyramid reconstruction approach are adjusted for biases due to different surveillance systems and are therefore a better basis for international comparisons than reported data.

Indexed as

Population SurveillanceAnimalsCampylobacterCampylobacter InfectionsCryptosporidiosisCryptosporidiumEnterobacteriaceaeEnterobacteriaceae InfectionsEuropeEuropean UnionFoodborne DiseasesGastroenteritisHumansIncidenceModels, BiologicalZoonoses

Identifiers

PMID23013659
PMCPMC9151593
OpenAlexW1991306852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.